Natera (NTRA) Income from Non-Controlling Interests (2016 - 2025)
Natera's (NTRA) quarterly Income from Non-Controlling Interests came in at $100000.0 in Q3 2025, down 83.14% YoY from $593000.0 in Q3 2024, and up 211.11% on a QoQ basis from -$90000.0 in Q2 2025.
Natera (NTRA) Income from Non-Controlling Interests (2016 - 2025) Analysis & Trends
Natera (NTRA) has 10 years of Income from Non-Controlling Interests data on file, last reported at $100000.0 in Q3 2025.
- Quarterly Income from Non-Controlling Interests fell 83.14% year-over-year to $100000.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $578000.0 (down 87.52% YoY) and the FY2024 annual result came in at $2.7 million, down 79.36% from the prior year.
- Income from Non-Controlling Interests rose to $100000.0 in Q3 2025, from -$90000.0 in the prior quarter.
- In the past five years, Income from Non-Controlling Interests ranged from a high of $4.6 million in Q1 2023 to a low of -$11.6 million in Q1 2022.
- A 5-year average of -$234000.0 and a median of $147000.0 in 2025 frame the typical range for Income from Non-Controlling Interests.
- Annual changes were most pronounced in 2022 — Income from Non-Controlling Interests slumped 993.88% — and 2023, when it jumped 218.52%.
- Tracing NTRA's Income from Non-Controlling Interests over 5 years: stood at -$3.8 million in 2021, then jumped by 185.94% to $3.2 million in 2022, then slipped by 28.83% to $2.3 million in 2023, then plunged by 81.78% to $421000.0 in 2024, then plunged by 76.25% to $100000.0 in 2025.
- The last three Income from Non-Controlling Interests figures came in at $100000.0 (Q3 2025), -$90000.0 (Q2 2025), and $147000.0 (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.86 Bn | 209.80 Bn | 8.34 Bn | 5.00 Mn |
| 2 | Danaher | 140.41 Bn | 136.07 Bn | 3.61 Bn | - |
| 3 | Idexx Laboratories | 46.33 Bn | 46.13 Bn | 779.09 Mn | - |
| 4 | Agilent Technologies | 39.71 Bn | 37.90 Bn | 990.00 Mn | - |
| 5 | Iqvia Holdings | 39.35 Bn | 37.27 Bn | 1.44 Bn | 2.00 Mn |
| 6 | Natera | 38.97 Bn | 37.87 Bn | 696.04 Mn | - |
| 7 | Illumina | 30.09 Bn | 28.92 Bn | 770.00 Mn | - |
| 8 | Mettler Toledo International | 28.70 Bn | 28.65 Bn | 650.22 Mn | - |
| 9 | Quest Diagnostics | 26.19 Bn | 25.56 Bn | 1.03 Bn | 14.00 Mn |
| 10 | Labcorp Holdings | 25.89 Bn | 24.91 Bn | 1.01 Bn | 200,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 100,000.00 |
| Jun 30, 2025 | -90,000.00 |
| Mar 31, 2025 | 147,000.00 |
| Dec 31, 2024 | 421,000.00 |
| Sep 30, 2024 | 593,000.00 |
| Jun 30, 2024 | 834,000.00 |
| Mar 31, 2024 | 893,000.00 |
| Dec 31, 2023 | 2.31 Mn |
| Sep 30, 2023 | 3.81 Mn |
| Jun 30, 2023 | 2.60 Mn |
| Mar 31, 2023 | 4.56 Mn |
| Dec 31, 2022 | 3.25 Mn |
| Sep 30, 2022 | -3.21 Mn |
| Jun 30, 2022 | -2.49 Mn |
| Mar 31, 2022 | -11.62 Mn |
| Dec 31, 2021 | -3.78 Mn |
| Sep 30, 2021 | -950,000.00 |
| Jun 30, 2021 | -756,000.00 |
| Mar 31, 2021 | -1.06 Mn |
| Dec 31, 2020 | -911,000.00 |